- /
- Supported exchanges
- / US
- / CAI.NASDAQ
Caris Life Sciences, Inc. Common Stock (CAI NASDAQ) stock market data APIs
Caris Life Sciences, Inc. Common Stock Financial Data Overview
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Caris Life Sciences, Inc. Common Stock (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Caris Life Sciences, Inc. Common Stock data using free add-ons & libraries
Get Caris Life Sciences, Inc. Common Stock Fundamental Data
Caris Life Sciences, Inc. Common Stock Fundamental data includes:
- Net Revenue: 452 M
- EBITDA: -184 595 008
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: -0.16
Get Caris Life Sciences, Inc. Common Stock End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Caris Life Sciences, Inc. Common Stock News
New
Cannaccord Genuity Asserts Hold Stance on Caris Life Sciences, Inc. (CAI) On Oncology Pipeline Development
Caris Life Sciences Inc. (NASDAQ:CAI) is one of the best biotech stocks to buy according to Wall Street analysts. On December 4, 2025, Caris Life Sciences (NASDAQ:CAI) announced it will present 19 bre...
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock
Key Points Connecticut-based fund Braidwell initiated a position in HNGE last quarter, adding 910,476 shares worth an estimated $44.7 million. The transaction represents 1.81% of Braidwell's reportab...
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound?
Key Points Connecticut-based fund Braidwell bought 2,378,655 shares of Acadia Pharmaceuticals in the third quarter, representing a new position valued at about $50.8 million as of September 30. The t...
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health Stock
Key Points Connecticut-based fund Braidwell initiated a position in HNGE last quarter, adding 910,476 shares worth an estimated $44.7 million. The transaction represents 1.81% of Braidwell's reportab...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.